Genprex Statistics

Total Valuation

Genprex has a market cap or net worth of $4.05 million. The enterprise value is -$2.69 million.

Market Cap	4.05M
Enterprise Value	-2.69M

Important Dates

The next estimated earnings date is Monday, May 20, 2024, after market close.

Earnings Date	May 20, 2024
Ex-Dividend Date	n/a

Share Statistics

Genprex has 1.91 million shares outstanding. The number of shares has increased by 14.09% in one year.

Shares Outstanding	1.91M
Shares Change (YoY)	+14.09%
Shares Change (QoQ)	+2.92%
Owned by Insiders (%)	0.85%
Owned by Institutions (%)	6.56%
Float	1.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.55
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.31, with zero debt.

Current Ratio	2.31
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -245.60% and return on invested capital (ROIC) is -419.01%.

Return on Equity (ROE)	-245.60%
Return on Assets (ROA)	-185.50%
Return on Capital (ROIC)	-419.01%
Revenue Per Employee	n/a
Profits Per Employee	-$1.19M
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -93.52% in the last 52 weeks. The beta is -0.63, so Genprex's price volatility has been lower than the market average.

Beta (1Y)	-0.63
52-Week Price Change	-93.52%
50-Day Moving Average	3.45
200-Day Moving Average	12.20
Relative Strength Index (RSI)	29.07
Average Volume (30 Days)	89,705

Short Selling Information

The latest short interest is 49,674, so 2.60% of the outstanding shares have been sold short.

Short Interest	49,674
Short Previous Month	69,946
Short % of Shares Out	2.60%
Short % of Float	2.64%
Short Ratio (days to cover)	0.86

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-31.08M
Pretax Income	-30.86M
Net Income	-30.86M
EBITDA	-30.85M
EBIT	-30.86M
Earnings Per Share (EPS)	-$22.56

Full Income Statement

Balance Sheet

The company has $6.74 million in cash and no debt, giving a net cash position of $6.74 million or $3.53 per share.

Cash & Cash Equivalents	6.74M
Total Debt	n/a
Net Cash	6.74M
Net Cash Per Share	$3.53
Equity / Book Value	7.42M
Book Value Per Share	3.88
Working Capital	4.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$24.74 million and capital expenditures $169, giving a free cash flow of -$24.74 million.

Operating Cash Flow	-24.74M
Capital Expenditures	169
Free Cash Flow	-24.74M
FCF Per Share	-$18.09

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genprex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.09%
Shareholder Yield	-14.09%
Earnings Yield	-761.96%
FCF Yield	-610.81%

Analyst Forecast

The average price target for Genprex is $10.00, which is 371.70% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	371.70%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 2, 2024. It was a reverse split with a ratio of 1:40.

Last Split Date	Feb 2, 2024
Split Type	Reverse
Split Ratio	1:40

Scores

Altman Z-Score	n/a
Piotroski F-Score	1